Multiple sclerosis in Kuwait: clinical and epidemiological study

A S Al-Din

Abstract

Eighty-nine cases of multiple sclerosis (70 Arabs) are reported from Kuwait. The prevalence is estimated to be 8.33 per 100,000 (age and sex adjusted to USA population). Kuwait thus emerges to be in the medium risk zone. No differences were found in the age of onset, clinical pattern and disability from the disease found in Europeans and North Americans.

Similar articles

Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians.

al-Din AS, Khogali M, Poser CM, al-Nassar KE, Shakir R, Hussain J, Behbahani K, Chadha G.J Neurol Sci. 1990 Dec;100(1-2):137-41. doi: 10.1016/0022-510x(90)90024-h.PMID: 2089130

Demographics and clinical characteristics of multiple sclerosis in Kuwait.

Alroughani R, Ahmed SF, Al-Hashel J.Eur Neurol. 2014;72(3-4):181-5. doi: 10.1159/000362270. Epub 2014 Sep 11.PMID: 25227152

Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.

Alroughani R, Ahmed SF, Behbahani R, Khan R, Thussu A, Alexander KJ, Ashkanani A, Nagarajan V, Al-Hashel J.Mult Scler. 2014 Apr;20(5):543-7. doi: 10.1177/1352458513504328. Epub 2013 Sep 11.PMID: 24025709

Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review.

Benamer HT, Ahmed ES, Al-Din AS, Grosset DG.J Neurol Sci. 2009 Mar 15;278(1-2):1-4. doi: 10.1016/j.jns.2008.12.001. Epub 2009 Jan 9.PMID: 19135686 Review.

[Development of epidemiologic studies of multiple sclerosis].

Cendrowski W.Postepy Hig Med Dosw. 1989;43(1):103-17.PMID: 2697871 Review. Polish.

Cited by

Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region.

Yamout BI, Assaad W, Tamim H, Mrabet S, Goueider R.Mult Scler J Exp Transl Clin. 2020 Jan 14;6(1):2055217319841881. doi: 10.1177/2055217319841881. eCollection 2020 Jan-Mar.PMID: 31984137 Free PMC article.

Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines.

Rivera VM.Biomedicines. 2018 Nov 30;6(4):112. doi: 10.3390/biomedicines6040112.PMID: 30513578 Free PMC article.

Epidemiologic evidence for multiple sclerosis as an infection.

Kurtzke JF.Clin Microbiol Rev. 1993 Oct;6(4):382-427. doi: 10.1128/CMR.6.4.382.PMID: 8269393 Free PMC article. Review.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. J Neurol Sci. 1971 Mar;12(3):307-18 - PubMed
  2.  
    1. Acta Neurol Scand. 1972;48(1):19-46 - PubMed
  3.  
    1. Acta Neurol Scand. 1975 Jan;51(1):1-11 - PubMed
  4.  
    1. Neurology. 1975 Sep;25(9):845-51 - PubMed
  5.  
    1. J Postgrad Med. 1975 Jan;21(1):1-9 - PubMed
  6.  
    1. Neurology. 1977 Feb;27(2):188-92 - PubMed
  7.  
    1. Acta Neurol Scand. 1980 Aug;62(2):65-80 - PubMed
  8.  
    1. Ann Neurol. 1983 Mar;13(3):227-31 - PubMed
  9.  
    1. Q J Med. 1952 Apr;21(82):135-67 - PubMed
  10.  
    1. Wien Z Nervenheilkd Grenzgeb. 1958;15(1-4):276-83 - PubMed
  11.  
    1. Neurology. 1961 Aug;11:686-94 - PubMed
  12.  
    1. Arch Neurol. 1962 Oct;7:253-63 - PubMed
  13.  
    1. Br Med J. 1950 Aug 19;2(4676):431-6 - PubMed
  14.  
    1. Proc Staff Meet Mayo Clin. 1963 Oct 9;38:457-66 - PubMed
  15.  
    1. Isr J Med Sci. 1971 Dec;7(12):1562-7 - PubMed

Page Navigation